First Trust Health Care AlphaDEX® ETF (FXH)

91.55 +1.36  +1.51% NYSE Arca May 29, 20:00 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 91.57
Discount or Premium to NAV -0.02%
Turnover Ratio 123.0%
1 Year Fund Level Flows 192.84M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 7.34% 8.80% 5.52% 23
3M 15.55% 15.55% 12.56% 18
6M 10.27% 10.31% 7.89% 30
YTD 8.73% 8.68% 4.13% 20
1Y 28.74% 28.70% 23.98% 27
3Y 12.36% 12.36% 12.88% 55
5Y 5.96% 5.97% 6.33% 51
10Y 15.15% 15.16% 15.53% 63
15Y -- -- 11.28% --
20Y -- -- 9.96% --
As of May 29, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.19% 0.19% 0.00%
Stock 99.81% 99.81% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of May 28, 2020

Region Exposure

Americas 99.16%
North America 99.16%
Latin America 0.00%
Greater Europe 0.84%
United Kingdom 0.84%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of May 28, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of May 28, 2020

Stock Market Capitalization

Giant 11.69%
Large 34.54%
Medium 48.78%
Small 4.99%
Micro 0.00%
As of May 28, 2020

Stock Style Exposure

Large Cap Value 5.54%
Large Cap Blend 25.02%
Large Cap Growth 16.96%
Mid Cap Value 4.57%
Mid Cap Blend 10.07%
Mid Cap Growth 35.51%
Small Cap Value 1.78%
Small Cap Blend 0.00%
Small Cap Growth 0.56%
As of May 28, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
NVST Envista Holdings Corp Ordinary Shares 2.71% 21.14 +0.96%
BIO Bio-Rad Laboratories Inc 2.63% 491.32 +2.97%
DXCM DexCom Inc 2.60% 378.31 +4.55%
SGEN Seattle Genetics Inc 2.54% 157.21 +3.73%
HUM Humana Inc 2.49% 410.65 +1.69%
HZNP Horizon Therapeutics PLC 2.38% 50.73 +4.06%
ALNY Alnylam Pharmaceuticals Inc 2.36% 135.27 +1.63%
UNH UnitedHealth Group Inc 2.36% 304.85 +0.29%
REGN Regeneron Pharmaceuticals Inc 2.29% 612.81 +5.98%
VRTX Vertex Pharmaceuticals Inc 2.25% 287.96 +3.81%
As of May 28, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index is a modified equal-dollar weighted index designed by IDI to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Growth
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name First Trust
Benchmark Index
StrataQuant Health Care TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Chris Peterson 4.12 yrs
Daniel Lindquist 12.99 yrs
David McGarel 12.99 yrs
Jon Erickson 12.99 yrs
Roger Testin 12.99 yrs
Stan Ueland 12.99 yrs

Net Fund Flows

1M 47.99M
3M 493.84M
6M 488.40M
YTD 468.32M
1Y 192.84M
3Y 459.74M
5Y -1.541B
10Y 801.83M
As of April 30, 2020

Risk Info

Beta (5Y) 0.9699
Max Drawdown (All) 43.70%
Historical Sharpe Ratio (10Y) 0.8481
Historical Sortino (All) 0.7286
30-Day Rolling Volatility 24.46%
Daily Value at Risk (VaR) 1% (All) 3.47%
Monthly Value at Risk (VaR) 1% (All) 18.71%

Fundamentals

Dividend Yield TTM (5-29-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 22.06
Weighted Average Price to Sales Ratio 2.174
Weighted Average Price to Book Ratio 3.621
Weighted Median ROE 15.55%
Weighted Median ROA 6.43%
Forecasted Dividend Yield 0.59%
Forecasted PE Ratio 20.30
Forecasted Price to Sales Ratio 2.038
Forecasted Price to Book Ratio 3.647
Number of Holdings 76
As of May 28, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 10.27%
Forecasted Book Value Growth 10.36%
Forecasted Cash Flow Growth 7.46%
Forecasted Earnings Growth 23.41%
Forecasted Revenue Growth 11.08%
As of May 28, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 5/8/2007
Termination Date
Last Annual Report Date 7/31/2019
Last Prospectus Date 12/2/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.